Bupropion and Restless Legs Syndrome

NCT00621517 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: Bupropion
DRUG: Placebo

Sponsor

East Tennessee State University